Herpes infections soar globally as new study reveals massive disease burden

Global estimates of HSV-1 and HSV-2 reveal a staggering disease burden, with 42.4 million new genital herpes cases and 8.8 billion GUD person-days in 2020, underscoring the urgent need for improved prevention strategies.

Amid measles outbreaks, U.K. launches vaccination ad campaign to boost childhood immunizations

LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily

February 29, 2024

ASBMB urges NIH to reconsider proposed policy on foreign researchers

On July 5, the American Society for Biochemistry and Molecular Biology raised concerns regarding proposed changes to the National Institutes of Health “Grants Policy Statement.”

July 7, 2023

Pharmalittle: We’re reading about a Blue Cross California deal for Humira, Gilead licensing an HIV drug, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.